Open AccessCorrection Notice: A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Lymphoma After Nivolumab Monotherapy Failure
Publication year - 2021
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/hs9.0000000000000619
Subject(s) - nivolumab , bendamustine , medicine , refractory (planetary science) , notice , oncology , hodgkin lymphoma , lymphoma , cancer , rituximab , materials science , immunotherapy , political science , law , composite material